P4.11E.07 Envafolimab Combined with Recombinant Human Endostatin and Chemotherapy for NSCLC
Back to course
Pdf Summary
Asset Subtitle
Chuanwang Miao
Meta Tag
Speaker Chuanwang Miao
Topic Metastatic NSCLC – Immunotherapy
Keywords
Phase II clinical study
Shandong First Medical University
Non-Small Cell Lung Cancer
Envafolimab
Recombinant Human Endostatin
platinum-based chemotherapy
objective response rate
disease control rate
advanced NSCLC treatment
Simcere Zaiming Pharmaceutical
Powered By